{"id":"https://openalex.org/W2005286581","doi":"https://doi.org/10.1016/j.juro.2010.01.012","title":"Tolerability of 5 mg Solifenacin Once Daily Versus 5 mg Oxybutynin Immediate Release 3 Times Daily: Results of the VECTOR Trial","display_name":"Tolerability of 5 mg Solifenacin Once Daily Versus 5 mg Oxybutynin Immediate Release 3 Times Daily: Results of the VECTOR Trial","publication_year":2010,"publication_date":"2010-03-30","ids":{"openalex":"https://openalex.org/W2005286581","doi":"https://doi.org/10.1016/j.juro.2010.01.012","mag":"2005286581","pmid":"https://pubmed.ncbi.nlm.nih.gov/20303119"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2010.01.012","doi":"https://doi.org/10.1016/j.juro.2010.01.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.01.012","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091477558","display_name":"Sender Herschorn","orcid":"https://orcid.org/0000-0001-8666-8236","observed_orcids":["https://orcid.org/0000-0001-8666-8236"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sender Herschorn","raw_affiliation_strings":["Department of Surgery/Urology, University of Toronto, Toronto, Ontario, Canada","Department of Surgery (Urology), University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery/Urology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Department of Surgery (Urology), University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009824768","display_name":"Lynn S. Stothers","orcid":"https://orcid.org/0000-0001-7841-1748","observed_orcids":["https://orcid.org/0000-0001-7841-1748"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lynn Stothers","raw_affiliation_strings":["University of British Columbia, Bladder Care Centre, Victoria, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of British Columbia, Bladder Care Centre, Victoria, British Columbia, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021181016","display_name":"Kevin V. Carlson","orcid":"https://orcid.org/0000-0002-6071-6110","observed_orcids":["https://orcid.org/0000-0002-6071-6110"]},"institutions":[{"id":"https://openalex.org/I168635309","display_name":"University of Calgary","ror":"https://ror.org/03yjb2x39","country_code":"CA","type":"education","lineage":["https://openalex.org/I168635309"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kevin Carlson","raw_affiliation_strings":["Division of Urology, University of Calgary, Calgary, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Urology, University of Calgary, Calgary, Alberta, Canada","institution_ids":["https://openalex.org/I168635309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069697640","display_name":"Blair Egerdie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Blair Egerdie","raw_affiliation_strings":["Urology Associates/Urologic Medical Research, Markham, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology Associates/Urologic Medical Research, Markham, Ontario, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020736798","display_name":"Jerzy B. Gajewski","orcid":"https://orcid.org/0000-0003-0769-583X","observed_orcids":["https://orcid.org/0000-0003-0769-583X"]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jerzy B. Gajewski","raw_affiliation_strings":["Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056109481","display_name":"Peter J. Pommerville","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Pommerville","raw_affiliation_strings":["Can-Med Clinical Research, Inc., Victoria, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Can-Med Clinical Research, Inc., Victoria, British Columbia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028126209","display_name":"Jane Ann Schulz","orcid":"https://orcid.org/0000-0002-8203-1390","observed_orcids":["https://orcid.org/0000-0002-8203-1390"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4210098043","display_name":"Royal Alexandra Hospital","ror":"https://ror.org/00wyx7h61","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I126859394","https://openalex.org/I4210098043"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jane Schulz","raw_affiliation_strings":["Department of Obstetrics and Gynecology, Royal Alexandra Hospital, University of Alberta, Edmonton, Alberta, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, Royal Alexandra Hospital, University of Alberta, Edmonton, Alberta, Canada","institution_ids":["https://openalex.org/I154425047","https://openalex.org/I4210098043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072713409","display_name":"Sidney B. Radomski","orcid":"https://orcid.org/0000-0002-7224-9660","observed_orcids":["https://orcid.org/0000-0002-7224-9660"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sidney Radomski","raw_affiliation_strings":["Department of Surgery/Urology, University of Toronto, Toronto, Ontario, Canada","Department of Surgery (Urology), University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery/Urology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Department of Surgery (Urology), University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012668978","display_name":"Harold P. Drutz","orcid":"https://orcid.org/0000-0001-9778-1066","observed_orcids":["https://orcid.org/0000-0001-9778-1066"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Harold Drutz","raw_affiliation_strings":["Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073537684","display_name":"Jack Barkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jack Barkin","raw_affiliation_strings":["Department of Surgery, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062045914","display_name":"Fran L. Paradiso\u2010Hardy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4392738316","display_name":"Astellas Pharma (Canada)","ror":"https://ror.org/041repn61","country_code":null,"type":"company","lineage":["https://openalex.org/I142395110","https://openalex.org/I4392738316"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Fran Paradiso-Hardy","raw_affiliation_strings":["Kitchener and Astellas Pharma Canada, Markham, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kitchener and Astellas Pharma Canada, Markham, Ontario, Canada","institution_ids":["https://openalex.org/I4392738316"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":6.7777,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.96534201,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"183","issue":"5","first_page":"1892","last_page":"1898"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10418","display_name":"Pelvic floor disorders treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/overactive-bladder","display_name":"overactive bladder","score":0.8870000243186951},{"id":"https://openalex.org/keywords/solifenacin","display_name":"solifenacin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/oxybutynin","display_name":"oxybutynin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antimuscarinic-agents","display_name":"antimuscarinic agents","score":0.8960000276565552},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8090000152587891},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7020000219345093},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.828000009059906},{"id":"https://openalex.org/keywords/nocturia","display_name":"nocturia","score":0.6779999732971191},{"id":"https://openalex.org/keywords/incontinence","display_name":"incontinence","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9266411066055298},{"id":"https://openalex.org/C2777844464","wikidata":"https://www.wikidata.org/wiki/Q1060922","display_name":"Oxybutynin","level":4,"score":0.9221265316009521},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9138593077659607},{"id":"https://openalex.org/C2779502394","wikidata":"https://www.wikidata.org/wiki/Q59575279","display_name":"Solifenacin","level":4,"score":0.8897243738174438},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4813997745513916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32342350482940674},{"id":"https://openalex.org/C2778941218","wikidata":"https://www.wikidata.org/wiki/Q331231","display_name":"Overactive bladder","level":3,"score":0.28345662355422974},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.24718087911605835},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.057874709367752075},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069464","descriptor_name":"Solifenacin Succinate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008333","descriptor_name":"Mandelic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011812","descriptor_name":"Quinuclidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014987","descriptor_name":"Xerostomia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D044005","descriptor_name":"Tetrahydroisoquinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D053201","descriptor_name":"Urinary Bladder, Overactive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.juro.2010.01.012","doi":"https://doi.org/10.1016/j.juro.2010.01.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.01.012","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},{"id":"pmid:20303119","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20303119","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of urology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Partnerships for the goals","score":0.6200000047683716,"id":"https://metadata.un.org/sdg/17"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W132581085","https://openalex.org/W1556806690","https://openalex.org/W1590256680","https://openalex.org/W1821426726","https://openalex.org/W1967347194","https://openalex.org/W1984503699","https://openalex.org/W2008545228","https://openalex.org/W2024813481","https://openalex.org/W2024975356","https://openalex.org/W2025195051","https://openalex.org/W2028950772","https://openalex.org/W2030052255","https://openalex.org/W2031825421","https://openalex.org/W2034782018","https://openalex.org/W2044969863","https://openalex.org/W2045365551","https://openalex.org/W2056759810","https://openalex.org/W2060290176","https://openalex.org/W2131770336","https://openalex.org/W2133603145","https://openalex.org/W2136548062","https://openalex.org/W2144433660","https://openalex.org/W2403713590","https://openalex.org/W2486289350","https://openalex.org/W2506210560","https://openalex.org/W2992968242"],"related_works":["https://openalex.org/W2043977360","https://openalex.org/W3170620413","https://openalex.org/W1981386590","https://openalex.org/W2328647547","https://openalex.org/W2514795679","https://openalex.org/W2072816571","https://openalex.org/W2560308546","https://openalex.org/W2050978783","https://openalex.org/W2513314346","https://openalex.org/W166248116"],"abstract_inverted_index":{"PURPOSE:":[0],"Although":[1],"antimuscarinic":[2],"treatment":[3,217,300],"is":[4,21],"indicated":[5],"for":[6,92],"overactive":[7,58],"bladder,":[8],"many":[9],"patients":[10,56,146,162,222,245,254],"discontinue":[11],"it":[12],"because":[13],"of":[14,35,54,104,132,174,205,288],"dry":[15,26,105,157,164,230,250,262],"mouth.":[16,251],"Of":[17,145,161],"available":[18],"antimuscarinics":[19],"oxybutynin":[20,42,88,150,179,237,274],"associated":[22],"with":[23,57],"the":[24,31,100,129,137],"highest":[25],"mouth":[27,106,158,165,231,263],"rate.":[28],"We":[29],"compared":[30],"safety":[32],"and":[33,69,102,123,126,136,172,178,182,186,202,209,264,273,284,292],"tolerability":[34],"5":[36,80,86,224,235],"mg":[37,41,81,87,225,236],"solifenacin":[38,82,148,177,226,247,256],"vs":[39,149,154,232],"15":[40],"immediate":[43,151,180,238,275],"release.":[44],"MATERIALS":[45],"AND":[46],"METHODS:":[47],"At":[48],"12":[49],"Canadian":[50],"centers":[51],"a":[52],"total":[53],"132":[55],"bladder":[59],"symptoms":[60],"(greater":[61],"than":[62],"1":[63],"urgency":[64],"episode":[65],"per":[66,74],"24":[67,75],"hours,":[68],"8":[70,93],"or":[71,85],"greater":[72],"micturitions":[73],"hours)":[76],"were":[77,141,266,277],"randomized":[78],"to":[79,216,261,299],"once":[83,227],"daily":[84,91,228],"3":[89,240],"times":[90,241],"weeks.":[94],"The":[95],"primary":[96],"end":[97,112,200,282],"point":[98],"was":[99,167],"incidence":[101],"severity":[103,166],"reported":[107,156,229,248],"after":[108],"direct":[109],"questioning.":[110],"Efficacy":[111],"points":[113],"(3-day":[114],"diary":[115],"documented":[116],"changes":[117,127],"in":[118,193,198,279],"urgency,":[119],"frequency,":[120],"incontinence,":[121],"nocturia":[122],"voided":[124],"volume),":[125],"on":[128,147,176,223,246,255],"Patient":[130,203,286],"Perception":[131,204,287],"Bladder":[133,139,206,211,289,294],"Condition":[134,207,290],"scale":[135,208,291],"Overactive":[138,210,293],"Questionnaire":[140,212,295],"evaluated":[142],"secondarily.":[143],"RESULTS:":[144],"release":[152,239,276],"35%":[153],"83%":[155],"(p":[159,189],"<0.0001).":[160],"reporting":[163],"graded":[168],"moderate":[169],"by":[170,184],"13%":[171,185],"42%":[173],"those":[175,233],"release,":[181],"severe":[183],"28%,":[187],"respectively":[188],"=":[190],"0.001).":[191],"Patients":[192],"each":[194],"group":[195],"showed":[196],"improvements":[197],"efficacy":[199,281],"points,":[201,283],"scores":[213],"from":[214,258,297],"baseline":[215,298],"end.":[218,301],"CONCLUSIONS:":[219],"Significantly":[220,243,252],"fewer":[221,244,253,268],"receiving":[234],"daily.":[242],"moderate/severe":[249],"withdrew":[257],"study":[259],"due":[260],"there":[265],"significantly":[267],"overall":[269],"adverse":[270],"events.":[271],"Solifenacin":[272],"efficacious":[278],"decreasing":[280],"improved":[285],"results":[296]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}